Changes in matrix metalloproteinases in diabetes patients’ tears after vitrectomy and the relationship with corneal epithelial disorder

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 6, 2015, Pages 3559-3564

  Matsumura, Takehiro ^a   Takamura, Yoshihiro ^a   Tomomatsu, Takeshi ^a   Arimura, Shogo ^a   Gozawa, Makoto ^a   Takihara, Yuji ^a   Inatani, Masaru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Diabetic keratopathy; Matrix metalloproteinase; MMP 10; Tear

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; STROMELYSIN 2;

ADULT; AGED; ARTICLE; CANNULA; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEAL EPITHELIAL DISORDER; DIABETIC PATIENT; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMAN; LACRIMAL FLUID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA MACULA HOLE; VITRECTOMY; ADVERSE EFFECTS; CASE CONTROL STUDY; DIABETES MELLITUS; METABOLISM; MIDDLE AGED; PERIOPERATIVE PERIOD; RETINA TEAR; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; PERIOPERATIVE PERIOD; RETINAL PERFORATIONS; TEARS; VITRECTOMY; YOUNG ADULT;

EID: 84939864670     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16489     Document Type: Article

References (39)

1. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care. 1998;21:143-156.
2. Herse PR. A review of manifestations of diabetes mellitus in the anterior eye and cornea. Am J Optom Physiol Opt. 1988;65: 224-230.
3. Schultz RO, Matsuda M, Yee RW, Edelhauser HF, Schultz KJ. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol. 1984;98:401-410.
4. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc. 1981;79:180- 199.
5. Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540-2553.
6. Bikbova G, Oshitari T, Tawada A, Yamamoto S. Corneal changes in diabetes mellitus. Curr Diabetes Rev. 2012;8:294-302.
7. Perry HD, Foulks GN, Thoft RA, Tolentino FI. Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol. 1978;96:1401-1403.
8. Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol. 1979;97:1076-1078.
9. Chung H, Tolentino FI, Cajita VN, Acosta J, Refojo MF. Reevaluation of corneal complications after closed vitrectomy. Arch Ophthalmol. 1988;106:916-919.
10. Virata SR, Kylstra JA, Singh HT. Corneal epithelial defects following vitrectomy surgery using hand-held, sew-on, and noncontact viewing lenses. Retina. 1999;19:287-290.
11. Kaji Y, Usui T, Oshika T, et al. Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci. 2000;41:362-368.
12. Sato E, Mori F, Igarashi S, et al. Corneal advanced glycation end precincts increase in patients with proliferative diabetic retinopathy. Diabetes Care. 2001;24:479-482.
13. Kinoshita JH, Fukushi S, Kador P, Merola LO. Aldose reductase in diabetic complications of the eye. Metabolism. 1979;28:462-469.
14. Cogan DG, Kinoshita JH, Kador PF, et al. NIH conference: aldose reductase and complications of diabetes. Ann Intern Med. 1984; 101:82-91.
15. Akagi Y, Yajima Y, Kador PF, Kuwabara T, Kinoshita JH. Localization of aldose reductase in the human eye. Diabetes. 1984;33:562-566.
16. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem. 1996;44:1469-1479.
17. Ljubimov AV, Huang ZS, Huang GH, et al. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem. 1998;46:1033-1041.
18. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res. 2002;21:1-14.
19. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827-839.
20. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol. 2004;4:617-629.
21. Manicone AM, McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 2008;19: 34-41.
22. Saghizadeh M, Brown DJ, Castellon R, et al. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol. 2001;158:723- 734.
23. Kabosova A, Kramerov AA, Aoki AM, Murphy G, Zieske JD, Ljubimov AV. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp Eye Res. 2003;77:211-217.
24. Tomomatsu T, Takamura Y, Kubo E, Akagi Y. Aldose reductase inhibitor counteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression. Diabetes Res Clin Pract. 2009;86:16-23.
25. Takamura Y, Matsumoto T, Tomomatsu T, Matsumura T, Takihara Y, Inatani M. Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats. Mol Vis. 2013;19:2477-2486.
26. Saghizadeh M, Epifantseva I, Hemmati DM, Ghiam CA, Brunken WJ, Ljubimov AV. Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing. Invest Ophthalmol Vis Sci. 2013;54:8172-8180.
27. Chotikavanich S, de Paiva CS, Li DQ, et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci. 2009;50:3203-3209.
28. Leonardi A, Brun P, Abatangelo G, Plebani M, Secchi AG. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052-3058.
29. Acera A, Vecino E, Duran JA. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci. 2013;54:8285-8291.
30. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL- 1 alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506-2512.
31. Solomon A, Dursun D, Liu ZG, Xie YH, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
32. Zhou L, Beuerman RW. Tear analysis in ocular surface diseases. Prog Retin Eye Res. 2012;31:527-550.
33. Uchino E, Sonoda S, Kinukawa N, Sakamoto T. Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay. Cytokine. 2006;33:36-40.
34. Fujita A, Uchino E, Otsuka H, et al. Ocular surface molecule after transconjunctival vitrectomy. Br J Ophthalmol. 2011;95:419-423.
35. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21: 221-232.
36. Sambursky R, Davitt WF III, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013;131:24-28.
37. Najafi L, Malek M, Valojerdi AE, et al. Dry eye and its correlation to diabetes microvascular complications in people with type 2 diabetes mellitus. J Diabetes Complications. 2013;27:459-462.
38. Kimura K, Teranishi S, Nishida T. Interleukin-1 beta-induced disruption of barrier function in cultured human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2009;50:597-603.
39. Kimura K, Teranishi S, Fukuda K, Kawamoto K, Nishida T. Delayed disruption of barrier function in cultured human corneal epithelial cells induced by tumor necrosis factor-alpha in a manner dependent on NF-kappa B. Invest Ophthalmol Vis Sci. 2008;49:565-571.